14,545,000 Shares ADVENTRX PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 3rd, 2006 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell up to an aggregate of 14,545,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) to certain investors (each an “Investor” and, collectively, the “Investors”). The Company desires to engage ThinkEquity Partners LLC (“ThinkEquity”) and Fortis Securities LLC (“Fortis” and together with ThinkEquity, the “Placement Agents”) as its exclusive placement agents as set forth herein in connection with such issuance and sale. ThinkEquity is acting as representative of the Placement Agents (the “Representative”). The Shares are more fully described in the Registration Statement (as hereinafter defined).
